Not “Additive Free” or “Natural” – FDA Issues Warning Letters to Commercial Tobacco Manufacturers

Today, the FDA announced that it is issuing warning letters to three tobacco manufacturers for the use of “Additive-Free” and/or “Natural” claims on cigarette labeling.

Six years ago, Congress gave the FDA the responsibility to oversee the manufacture, marketing, distribution, and sale of tobacco products. A rigorous compliance and enforcement program helped FDA monitor regulated industry’s compliance with the laws designed to protect the public health generally and to reduce tobacco use by minors.

The FDA announced today that through ongoing surveillance efforts, they are issuing warning letters to three cigarette manufacturers, who describe their cigarettes on product labeling as “additive free” and/or “natural.” The warning letters are for violations of Section 911 of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FDA has determined that these products, described as “natural” and “additive-free” on their labeling, need a modified risk tobacco product (MRTP) order from the agency before they can be legally introduced as such into interstate commerce.

MRTPs can only be introduced into interstate commerce after scientific evidence to support them has been submitted to the FDA, and the FDA has issued an order permitting their marketing. To date, the FDA has not issued any orders that would permit label claims of reduced risk or harm to users and nonusers. These requirements were put in place so that American tobacco consumers are not misled about the harms of tobacco products.

Manufacturers must ensure their tobacco products and all related labeling and/or advertising comply with the FD&C Act and the FDA’s implementing regulations. Failure to obey federal tobacco laws may result in the FDA initiating action, including, but not limited to, civil money penalties, criminal prosecution, seizure, and/or injunction.

A manufacturer who seeks to claim that a product poses fewer risks than other tobacco products may submit a MRTP application to the FDA with scientific evidence to support that claim.

Read the full press release on this announcement here.

Anyone can report a potential tobacco-related violation of the FD&C Act by using the FDA’s Potential Tobacco Product Violation Reporting Form.

×

Upcoming Events

Attending any of these upcoming events? Have other events to share? Let us know! Email us at NNN@ITCMI.ORG to share your event information or to get on our list serve for event updates.

 

2025 National Conference on Tobacco or Health | SAVE THE DATE | LEARN MORE

2025 National Conference on Tobacco or Health; presented by National Network of Public Health Institutes; Chicago, Illinois | LEARN MORE AND REGISTER

NIHB presents National Tribal Health Conference | Sheraton Grand at Wildhorse Pass in Chandler, Arizona | LEARN MORE AND REGISTER

75 Years Later:  The Impact of the 1950 Papers on Smoking and Lung Cancer | This symposium will celebrate the achievements that have occurred over the past 75 years in the fields of tobacco control, lung cancer epidemiology and causal inference.  Two seminal papers on lung cancer and smoking initiated these three areas of scholarship in 1950.  Since then, significant public health, policy, and research contributions have been made by scholars around the world.  In this symposium, speakers will highlight such accomplishments and present their current research in these fields. | DOWNLOAD FLIER | REGISTER HERE

Association of American Indian Physicians 53rd Annual Meeting | Hyatt Regency Seattle in Seattle, Washington | LEARN MORE AND REGISTER

National Lung Cancer Screening Day | Now in its fourth year, this initiative is kpowered by a dynamic collaboration among the American Cancer Society's National Lung Cancer Roundtable, GO2 for Lung Cancer, the Radiology Health Equity Coalition, and the American College of Radiology. | LEARN MORE